CSIMarket
 
Jupiter Neurosciences Inc   (NASDAQ: JUNS)
 

Jupiter Neurosciences Inc's Suppliers Performance

JUNS's Supply Chain




 
JUNS Costs vs Sales of Suppliers Growth Jupiter Neurosciences Inc's cost of sales deteriorated by 0 % year on year, relative to one quarter ago cost of sales fell by -27.07 % in Q2.

• More on JUNS Suppliers



Jupiter Neurosciences Inc's cost of sales deteriorated by 0 % year on year, compare to one quarter ago cost of sales fell by -27.07 % in Q2.

• More on JUNS Suppliers




Jupiter Neurosciences Inc's Comment on Supply Chain


Jupiter requires its manufacturing partners to comply with the FDA's Current Good Manufacturing Practices (cGMP) under 21 CFR Part 111 to ensure product safety and quality, including for products such as JOTROL™ and ingredients like CoQ10. Any change in suppliers or initial manufacturing steps necessitates a separate agreement with Aquanova. Compliance with FDA regulations is essential to prevent recalls, fines, or reputational harm. Internationally, Jupiter adheres to regulatory requirements from authorities such as the European Food Safety Authority (EFSA) for novel foods including JOTROL™ and NovaSOL® Astaxanthin, and manages complex approval processes in markets like China and Japan. Additionally, Jupiter has established service agreements related to chemistry, manufacturing, and controls (CMC), regulatory affairs, and clinical trial management with companies operating in Southeast Asia to support business development in that region.

Jupiter Neurosciences Inc's Comment on Supply Chain


Jupiter requires its manufacturing partners to comply with the FDA's Current Good Manufacturing Practices (cGMP) under 21 CFR Part 111 to ensure product safety and quality, including for products such as JOTROL™ and ingredients like CoQ10. Any change in suppliers or initial manufacturing steps necessitates a separate agreement with Aquanova. Compliance with FDA regulations is essential to prevent recalls, fines, or reputational harm. Internationally, Jupiter adheres to regulatory requirements from authorities such as the European Food Safety Authority (EFSA) for novel foods including JOTROL™ and NovaSOL® Astaxanthin, and manages complex approval processes in markets like China and Japan. Additionally, Jupiter has established service agreements related to chemistry, manufacturing, and controls (CMC), regulatory affairs, and clinical trial management with companies operating in Southeast Asia to support business development in that region.







JUNS's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Jupiter Neurosciences Inc 1.49 0.00 -9.20 5
SUBTOTAL 0.00 0.00 0.00 -


Sources: Jupiter Neurosciences Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Jupiter Neurosciences Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.